Apryl Hawthorne Moss, ARNP

Apryl Moss practices at Comprehensive Hematology Oncology in Trinity, Florida.

Apryl Moss' NPI, 1831671643, was assigned on August 29, 2018. Apryl Moss holds Florida license APRN9334284.

Apryl Moss' primary practice is Comprehensive Hematology Oncology, at 3611 Little Rd, Trinity, FL 34655 in Pasco County. The practice phone is (727) 344-6570.

Apryl Moss' primary practice is Comprehensive Hematology Oncology in Trinity, Florida. The medical group on file is Access 2 Health Care Physicians. Dmand AI also links Apryl Moss to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Apryl Moss practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Apryl Moss' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Apryl Moss is licensed in Florida.

CMS data shows 104 Medicare services from Apryl Moss across 3 procedure codes in 2024, for 44 Medicare patients. Medicare paid $895 for them. Every service was in an office.

CMS counts 44 Medicare patients who saw Apryl Moss in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Apryl Moss' median patient age at 76, with 51% women.

In 2024, Apryl Moss wrote 763 Medicare Part D claims for 308 patients. 94% of them were for generic drugs. CMS names the drug for 544 of them, across 20 drugs with 11 or more claims each, at $25,436 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Apryl Moss for performance year 2024, reported as part of a group. Apryl Moss accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 250 general payments to Apryl Moss from 46 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 97% of the total. Novartis Pharmaceuticals Corporation paid the most, $577.